H-beta-Chloro-Ala-OH

H-beta-Chloro-Ala-OH is a β-chloro substituted alanine derivative bearing a free carboxylic acid and a stereodefined α-amino acid framework, which places a reactive C-Cl bond at the β-position relative to the chiral center. The molecule's amino acid backbone supports standard amino acid coupling chemistry, while the β-chloride introduces a handle for nucleophilic substitution, elimination, and downstream functional group interconversion. The presence of an unprotected carboxylic acid and amino functionality in the hydrochloride-free form (as supplied) typically necessitates controlled protection during peptide synthesis to prevent side reactions and to maintain chemoselectivity. As a chiral amino acid intermediate, H-beta-Chloro-Ala-OH can be carried through sequences that convert the β-chloride into β-functionalized analogs relevant to peptide construction and synthetic method development.

1. Peptide Synthesis

H-beta-Chloro-Ala-OH is applied in peptide synthesis and peptide building block preparation where β-chloro alanine analogs are incorporated to introduce a masked electrophile into peptide backbones. The amino acid structure supports conversion to an N-protected form and coupling using standard peptide bond-forming strategies, while the β-chloride can be retained under compatible conditions or transformed after assembly. Side-chain reactivity at the β-position enables post-coupling derivatization to generate β-substituted residues, including β-heteroatom substituted or β-functionalized motifs that affect local conformation and reactivity. Downstream peptide analog construction benefits from the ability to manage stereochemistry at the α-center while using the β-chloride as a controlled functional handle for sequential synthetic steps.

2. Amino Acid Derivatization

H-beta-Chloro-Ala-OH is utilized for amino acid derivatization and side-chain functionalization through nucleophilic substitution at the β-chloride. The β-chloro substituent can participate in substitution to install nucleophiles such as azide, thiolates, amines, or oxygen-based nucleophiles, enabling access to β-amino, β-thioether, β-alkoxy, or β-azido alanine derivatives. The free carboxylic acid and amino acid stereocenter allow the resulting products to remain compatible with further peptide coupling or to serve as chiral intermediates for non-peptidic scaffolds. Synthetic sequences can treat H-beta-Chloro-Ala-OH as a chiral platform for generating β-functionalized amino acid building blocks used in structure-activity relationship studies and synthetic organic chemistry.

3. Chiral Building Block Development

H-beta-Chloro-Ala-OH serves as a chiral amino acid intermediate for stereoselective synthesis of β-functionalized alanine derivatives and related chiral fragments. The α-stereocenter provides stereochemical control, while the β-chloride offers a defined electrophilic site that can be converted into substituents with retention or inversion depending on the substitution chemistry applied. The amino acid functionality supports conversion into protected derivatives for compatibility with multi-step synthesis, including orthogonal protection strategies that separate N-protection from β-functional group transformations. The resulting chiral building blocks can be used to construct peptidomimetics, constrained amino acid motifs, and other stereochemically defined intermediates for fine chemical synthesis and applied research.

4. Chemical Biology Probes

H-beta-Chloro-Ala-OH can be employed in chemical biology research as a β-electrophilic amino acid analog for labeling and probe development in biomolecule modification workflows. The β-chloride provides a reactive moiety that may undergo controlled reactions with nucleophilic residues or capture reagents, while the amino acid backbone supports incorporation into peptides or linkers that localize the electrophile. The carboxylic acid and amino group enable tethering strategies after appropriate protection and activation, facilitating the generation of functional conjugates used to interrogate binding sites or reaction pathways. Downstream use includes preparation of electrophile-bearing peptide fragments and analytical standards that support mechanistic studies of amino acid reactivity and biomolecular recognition.

5. Pharmaceutical Intermediate Preparation

H-beta-Chloro-Ala-OH is relevant to pharmaceutical intermediate preparation where β-functionalized alanine derivatives can serve as building blocks for medicinal chemistry and process chemistry routes. The β-chloride enables conversion into β-substituted motifs that can modulate physicochemical properties, conformational preferences, and reactivity profiles of larger intermediates. The amino acid backbone supports protection and activation to integrate into synthetic sequences that assemble peptide-like structures, peptidomimetics, or amino acid-derived scaffolds. Industrial manufacturing utility arises from the feasibility of using H-beta-Chloro-Ala-OH as a defined chiral precursor for downstream derivatization steps that generate controlled electrophilic or functionalized intermediates for specialty chemical production.

6. Process Chemistry Intermediate

H-beta-Chloro-Ala-OH is suitable for process chemistry intermediate applications in the synthesis of β-functionalized amino acid derivatives under controlled chemoselective transformations. The β-chloride provides a discrete reactive site that can be converted into a range of functional groups while the amino acid framework can be protected to manage compatibility with coupling reagents and purification conditions. The stereodefined α-center supports consistent stereochemical outcomes across scale-up-relevant sequences, and the carboxylic acid functionality enables formation of activated derivatives for subsequent steps. Downstream chemical manufacturing can leverage H-beta-Chloro-Ala-OH as a chiral electrophile-containing intermediate for producing fine chemicals, peptide building blocks, and functionalized amino acid reagents used in industrial and research settings.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review